Research output per year
Research output per year
Personal profile
Headline
ASSISTANT PROFESSOR
Fingerprint
Dive into the research topics where Jing Liu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
An MDM2 degrader for treatment of acute leukemias
Marcellino, B. K., Yang, X., Ümit Kaniskan, H., Brady, C., Chen, H., Chen, K., Qiu, X., Clementelli, C., Herschbein, L., Li, Z., Elghaity-Beckley, S., Arandela, J., Kelly, B., Hoffman, R., Liu, J., Xiong, Y., Jin, J. & Shih, A. H., Feb 2023, In: Leukemia. 37, 2, p. 370-378 9 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Dissecting and targeting noncanonical functions of EZH2 in multiple myeloma via an EZH2 degrader
Yu, X., Wang, J., Gong, W., Ma, A., Shen, Y., Zhang, C., Liu, X., Cai, L., Liu, J., Wang, G. G. & Jin, J., 24 Mar 2023, In: Oncogene. 42, 13, p. 994-1009 16 p.Research output: Contribution to journal › Article › peer-review
3 Scopus citations -
Bridged Proteolysis Targeting Chimera (PROTAC) Enables Degradation of Undruggable Targets
Xiong, Y., Zhong, Y., Yim, H., Yang, X., Park, K. S., Xie, L., Poulikakos, P. I., Han, X., Xiong, Y., Chen, X., Liu, J. & Jin, J., 14 Dec 2022, In: Journal of the American Chemical Society. 144, 49, p. 22622-22632 11 p.Research output: Contribution to journal › Article › peer-review
13 Scopus citations -
Discovery of a dual WDR5 and Ikaros PROTAC degrader as an anti-cancer therapeutic
Li, D., Yu, X., Kottur, J., Gong, W., Zhang, Z., Storey, A. J., Tsai, Y. H., Uryu, H., Shen, Y., Byrum, S. D., Edmondson, R. D., Mackintosh, S. G., Cai, L., Liu, Z., Aggarwal, A. K., Tackett, A. J., Liu, J., Jin, J. & Wang, G. G., 10 Jun 2022, In: Oncogene. 41, 24, p. 3328-3340 13 p.Research output: Contribution to journal › Article › peer-review
8 Scopus citations -
Discovery of Potent, Selective, and in Vivo Efficacious AKT Kinase Protein Degraders via Structure-Activity Relationship Studies
Yu, X., Xu, J., Shen, Y., Cahuzac, K. M., Park, K. S., Dale, B., Liu, J., Parsons, R. E. & Jin, J., 24 Feb 2022, In: Journal of Medicinal Chemistry. 65, 4, p. 3644-3666 23 p.Research output: Contribution to journal › Article › peer-review
17 Scopus citations
Press/Media
-
Australia Patent: Application for 'Compositions and methods for treating CDK4/6-mediated cancer' Lapses
Poulikos Poulikakos, Jing Liu & Jian Jin
7/07/23
1 item of Media coverage
Press/Media
-
Australia Patent: Application for 'Serine threonine kinase (AKT) degradation / disruption compounds and methods of use' Lapses
Ramon Parsons, Jing Liu & Jian Jin
10/03/23
1 item of Media coverage
Press/Media
-
U.S. Patents Awarded to Inventors in New Jersey (Jan. 5)
Yang Yang, Poulikos Poulikakos, Jing Liu & Jian Jin
5/01/23
1 item of Media coverage
Press/Media